UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Reduced by Arrow Financial Corp

Arrow Financial Corp decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 42.9% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,326 shares of the healthcare conglomerate's stock after selling 3,250 shares during the period. Arrow Financial Corp's holdings in UnitedHealth Group were worth $2,266,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also bought and sold shares of UNH. Geode Capital Management LLC raised its stake in shares of UnitedHealth Group by 1.6% during the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock valued at $10,068,869,000 after acquiring an additional 319,515 shares in the last quarter. Capital International Investors raised its stake in shares of UnitedHealth Group by 6.2% during the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock valued at $7,899,905,000 after acquiring an additional 906,365 shares in the last quarter. Norges Bank bought a new position in UnitedHealth Group during the 4th quarter worth about $6,375,744,000. Northern Trust Corp grew its holdings in UnitedHealth Group by 12.5% during the 4th quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock worth $4,807,527,000 after acquiring an additional 1,058,488 shares in the last quarter. Finally, Franklin Resources Inc. grew its holdings in UnitedHealth Group by 10.7% during the 4th quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock worth $4,514,178,000 after acquiring an additional 861,854 shares in the last quarter. Institutional investors own 87.86% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the stock. Wolfe Research dropped their target price on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a report on Tuesday, May 20th. Raymond James Financial lowered shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research report on Wednesday, May 14th. Truist Financial decreased their price target on shares of UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating for the company in a research report on Wednesday, July 16th. UBS Group reaffirmed a "buy" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Finally, Wells Fargo & Company reaffirmed an "overweight" rating on shares of UnitedHealth Group in a research report on Friday, June 6th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and fifteen have issued a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $394.43.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn purchased 1,533 shares of the stock in a transaction dated Wednesday, May 14th. The stock was acquired at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the acquisition, the director owned 6,033 shares of the company's stock, valued at $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the transaction, the chief executive officer owned 10,398 shares of the company's stock, valued at $3,171,390. This represents a 5.36% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have bought 109,408 shares of company stock valued at $31,607,768. Company insiders own 0.28% of the company's stock.

UnitedHealth Group Trading Up 2.6%

UNH traded up $7.27 on Wednesday, hitting $292.40. The company had a trading volume of 12,968,838 shares, compared to its average volume of 7,893,810. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The firm has a market cap of $265.25 billion, a P/E ratio of 12.24, a PEG ratio of 1.38 and a beta of 0.45. The company's fifty day moving average price is $304.47 and its 200 day moving average price is $432.39. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were given a $2.21 dividend. The ex-dividend date was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.02%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio (DPR) is currently 37.02%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.